Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
11 studies found for:    ALPORT SYNDROME, X-LINKED
Show Display Options
Rank Status Study
1 Recruiting Alport Syndrome Treatments and Outcomes Registry
Condition: Alport Syndrome
Intervention:
2 Recruiting European Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome
Conditions: Alport Syndrome;   Hereditary Kidney Disease;   Pediatric Kidney Disease;   Thin Basement Membrane Disease;   Familial Benign Hematuria
Interventions: Drug: ACE-inhibitor;   Drug: AT1-inhibitor;   Drug: HMG-Coenzyme inhibitor (statin);   Drug: Spironolactone;   Drug: Paricalcitol
3 Recruiting ATHENA: Natural History of Disease Study in Alport Syndrome Patients
Condition: Alport Syndrome Patients With eGFR Between 45-90 ml/Min/1.73 m2
Intervention:
4 Active, not recruiting Multi-center Controlled Clinical Trials in Alport Syndrome-A Feasibility Study
Condition: Alport Syndrome
Intervention:
5 Completed A Prospective Study of Microalbuminuria in Untreated Boys With Alport Syndrome
Condition: Alport Syndrome
Intervention:
6 Completed Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport Syndrome
Condition: Alport Syndrome
Interventions: Drug: ACE I, ATA II and Statins;   Drug: Benazepril, Valsartan and Fluvastatin
7 Recruiting Study of Weekly RG-012 Injections in Patients With Alport Syndrome
Condition: Alport Syndrome
Interventions: Drug: RG-012;   Drug: Placebo
8 Recruiting Biomarker for Patient With Alport Disease or Highly Suspected for Alport Disease
Conditions: Nephritis, Hereditary;   Alport Syndrome;   Alport Syndrome, Autosomal Dominant;   Alport Syndrome, Autosomal Recessive;   Hematuria-Nephropathy-Deafness Syndrome
Intervention:
9 Terminated Human Urine Sample Collection for Alport Nephropathy Biomarker Studies
Condition: Alport Syndrome
Intervention:
10 Recruiting Efficacy and Safety Study to Delay Renal Failure in Children With Alport Syndrome
Condition: Renal Insufficiency, Chronic
Interventions: Drug: Ramipril;   Drug: placebo to ramipril
11 Completed Urinary Biomarkers of the Progression of Alport Kidney Disease
Condition: Alport Syndrome
Intervention:

Indicates status has not been verified in more than two years